Abstract:
In this article are presented some aspects concerning to the pathography, etiology, pathogenesis, epidemiology, prevention and therapy of the wallroth, caused by the Erysiphe communis f. cruciferarum fungi, argumentation of the state testing of new phytosanitary products against the disease, as well as the experimental results towards the possibility of homologation and use against autumn rapeseed wallroth of the FN-1, WG fungicide of the „Proto-Protect” firm, Great Britain